Literature DB >> 17105834

Angiotensin-converting enzyme inhibitors for bevacizumab-induced hypertension.

Murat Dincer, Kadri Altundag.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105834     DOI: 10.1345/aph.1H244

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  13 in total

1.  Chemotherapy-induced Cardiotoxicity.

Authors:  Maria Florescu; Mircea Cinteza; Dragos Vinereanu
Journal:  Maedica (Bucur)       Date:  2013-03

2.  Short-term effects of intravitreal ranibizumab and bevacizumab administration on 24-h ambulatory blood pressure monitoring recordings in normotensive patients with age-related macular degeneration.

Authors:  A Sengul; R Rasier; C Ciftci; O Artunay; A Kockar; H Bahcecioglu; E Yuzbasioglu
Journal:  Eye (Lond)       Date:  2017-01-06       Impact factor: 3.775

Review 3.  Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.

Authors:  Hui-Ming Chang; Tochukwu M Okwuosa; Tiziano Scarabelli; Rohit Moudgil; Edward T H Yeh
Journal:  J Am Coll Cardiol       Date:  2017-11-14       Impact factor: 24.094

4.  Acceleration of Proteinuria without Significant Impact on Renal Function and Its Protection by Angiotensin II Receptor Blocker in Rats Treated with Axitinib.

Authors:  Satoshi Imai; Hideaki Miyake; Masato Fujisawa
Journal:  Target Oncol       Date:  2016-06       Impact factor: 4.493

Review 5.  Bevacizumab-induced hypertension: Clinical presentation and molecular understanding.

Authors:  Megan Li; Deanna L Kroetz
Journal:  Pharmacol Ther       Date:  2017-09-04       Impact factor: 12.310

Review 6.  Angiogenic inhibitors for older patients with advanced colorectal cancer: does the age hold the stage?

Authors:  Giuseppe Aprile; Caterina Fontanella; Eufemia Stefania Lutrino; Laura Ferrari; Mariaelena Casagrande; Giovanni Gerardo Cardellino; Gerardo Rosati; Gianpiero Fasola
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

Review 7.  Tyrosine Kinase Inhibitor-Induced Hypertension.

Authors:  Megha Agarwal; Nidhi Thareja; Melody Benjamin; Andre Akhondi; George D Mitchell
Journal:  Curr Oncol Rep       Date:  2018-06-21       Impact factor: 5.075

Review 8.  Pharmacogenetics of Chemotherapy-Induced Cardiotoxicity.

Authors:  Vivian Y Chang; Jessica J Wang
Journal:  Curr Oncol Rep       Date:  2018-04-30       Impact factor: 5.075

9.  Vascular endothelial growth factor inhibitor-induced hypertension: basics for primary care providers.

Authors:  Carmen P Escalante; Ali Zalpour
Journal:  Cardiol Res Pract       Date:  2011-05-10       Impact factor: 1.866

Review 10.  Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.

Authors:  Adriana Albini; Giuseppina Pennesi; Francesco Donatelli; Rosaria Cammarota; Silvio De Flora; Douglas M Noonan
Journal:  J Natl Cancer Inst       Date:  2009-12-10       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.